# Tanvex BioPharma USA, Inc – FDA Inspection, May 2, 2019

Source: https://www.keypedia.com/records/fda_inspections/tanvex-biopharma-usa-inc/c5b7b252-bbc1-4931-a920-68fb24006170
Source feed: FDA_Inspections

> FDA inspection 1095764 of Tanvex BioPharma USA, Inc, May 02, 2019. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1095764
- Company Name: Tanvex BioPharma USA, Inc
- Inspection Date: 2019-05-02
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 0

## Related Documents

- [FDA Inspection 1198180 - 2023-01-24](https://www.keypedia.com/records/fda_inspections/tanvex-biopharma-usa-inc/fa8011ad-a7f3-41ae-b1f0-e2e41019a098)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/amanda-l-fyles/4a00278a-a7c5-4751-a8b7-6c0ce2e24272)
- Issuing Officer
- [Issuing Officer](https://www.keypedia.com/people/frances-namuswe/d64cc7a2-3840-41c9-ae6c-fe225a651369)
- Issuing Officer
- [FDA Associated Person](https://www.keypedia.com/people/thuy-t-nguyen/1cfb5467-f0b7-49b8-85c1-00373692e35e)

Company: https://www.keypedia.com/companies/tanvex-biopharma-usa-inc/03dcd4a5-e896-45c2-9c1f-1c90a4f9544d

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b